DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Aktueller Standort:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Cardiology Homepage

MaxQ AI launches ACCIPIO Ax, slice-level intracranial hemorrhage (ICH) detection and preview in the US and EU

SCAI and ACVP release consensus statement on cardiovascular catheterization laboratory economics

SCAI releases multi-society endorsed consensus on the classification stages of cardiogenic shock

Dale introduces new hold-n-place catheter securement products

Philips launches new IntraSight interventional applications platform to integrate intravascular imaging and physiology

Intelligent data analytics software solution comes to electrophysiology with launch of Biosense Webster's CARTONET

RIA Endovascular Clinic opens first interventional suite in Denver metro area

Data suggests new guidelines in stroke care have led to record numbers of patients treated

Gore receives FDA approval for the GORE TAG conformable thoracic stent graft with ACTIVE CONTROL

Machine learning overtakes humans in predicting death or heart attack

Leading vascular surgeon presents comparative data analysis on EndoAVF procedures at Society of Interventional Radiology 2019

Press releases may be edited for formatting or style
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Robert Shahverdyan, MD, Head of the Vascular Access Center at Asklepios Klinik Barmbek in Hamburg, Germany, presented his experience performing Endovascular AV Fistula Creation (endoAVF) techniques at the Society of Interventional Radiology (SIR) 2019 Annual Meeting last month in Austin, Texas. In his presentation, he shared data that showed that the FDA cleared Ellipsys® Vascular Access System from Avenu Medical, Inc., was the preferred technique compared to other approaches.

Ellipsys, an innovative, minimally-invasive catheter-based system designed for End-Stage Renal Disease (ESRD) patients requiring hemodialysis, provides physicians and patients access to a unique non-surgical option for AV fistula creation. In his heavily attended presentation, considered to be the highlight of this year’s SIR event, Dr. Shahverdyan outlined the comparative benefits of using Ellipsys when compared to other available technology. Ellipsys’ benefits, as outlined by Dr. Shahverdyan, included: faster procedure time; no need for x-rays or contrast agents; and a simpler procedure to perform overall.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



“Dr. Shahverdyan’s compelling analysis and data demonstrate that Ellipsys is faster and safer than any other approach,” said Ed Chang, Avenu’s Co-Founder and VP of Marketing. “And that it has clearly emerged as the gold standard for EndoAVF procedures.”

SIR 2019 was an active event for Avenu and Ellipsys. In addition to Dr. Shahverdyan’s presentation, another study centered around the use of Ellipsys, titled “The Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula Creation for Hemodialysis Access,” led by Jeffrey H.Hull, M.D. of Richmond Vascular Center, was selected by the editors of the Journal of Vascular and Interventional Radiology (JVIR) as the “Outstanding Clinical Study of the Year,” the Society’s top award. Dr. Hull’s paper was chosen by JVIR editorial board members, from among hundreds of reviewed manuscripts published in 2018 and singled out as the most essential, best-in-class research conducted in interventional radiology in the last year. The award was presented to Dr. Hull at SIR.


About Avenu Medical
Avenu Medical, Inc. was founded in 2010 to pursue unmet clinical needs in the ESRD and vascular access market. The company has developed the Ellipsys Vascular Access System which is an innovative, ultrasound-guided, single catheter endoAVF system used to percutaneously create an arteriovenous (AV) fistula for hemodialysis access.

Back to HCB News
  Pages: 1

Cardiology Homepage


You Must Be Logged In To Post A Comment

Werben
Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Übersicht
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Gesundheitsdienstleister
Alle Gesundheitsdienstleister-Tools anzeigen
Jobs/Training
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifiziert
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Service-Techniker Forum
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED